Antitrust Antitrust

Challenge by API suppliers to SAMR decision likely to see more hearings in Beijing court

By MLex Staff
  • 27 Aug 2021 01:59
  • 27 Aug 2021 01:59
A Beijing court is likely to hold further hearings on legal challenges by suppliers of active pharmaceutical ingredients to a decision by the country’s top competition regulator to impose record antitrust penalties on the companies, MLex has learned.
Last April, the State Administration for Market Regulation, or SAMR, announced a penalty

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Discover MLex

Stay on top of global regulatory developments

Latest News